US Patent Issued to BAYER PHARMA on Nov. 25 for "Gadolinium chelate compounds for use in magnetic resonance imaging" (German Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,696, issued on Nov. 25, was assigned to BAYER PHARMA AG (Berlin).

"Gadolinium chelate compounds for use in magnetic resonance imaging" was invented by Markus Berger (Berlin), Jessica Lohrke (Berlin), Christoph-Stephan Hilger (Berlin), Gregor Jost (Berlin), Thomas Frenzel (Berlin), Detlev Suelzle (Berlin), Johannes Platzek (Berlin), Olaf Panknin (Berlin) and Hubertus Pietsch (Kleinmachnow, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "An aqueous pharmaceutical composition including compound having the formula of tetragadolinium [4,10-bis(carboxylatomethyl)-7-{-3,6,12,15-tetraoxo-16-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododeca...